A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease
Abstract Diabetic kidney disease (DKD), also known as diabetic nephropathy, is the leading cause of renal impairment and end-stage renal disease. Patients with diabetes are at risk for DKD because of poor control of their blood glucose, as well as nonmodifiable risk factors including age, ethnicity,...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-03-01
|
| Online Access: | https://doi.org/10.1038/s41598-023-31701-w |
